Rowan Walrath (@bosbizrowan) 's Twitter Profile
Rowan Walrath

@bosbizrowan

Covering life sciences at @BosBizJournal. More often found at @rowanwalrath. Fully vaxed, for planning purposes. she/her. [email protected]

ID: 103917090

linkhttp://www.bizjournals.com/boston calendar_today11-01-2010 17:34:26

6,6K Tweet

3,3K Followers

668 Following

Don Seiffert: @donseiffert.bsky.social (@seiffertdon) 's Twitter Profile Photo

Ahead of Boston Scientific Q3 earnings later this week, analysts say the medical device company has a "higher level of risk" to Covid-19 than other healthcare companies, reports Rowan Walrath $BSX bizj.us/1qcipq

Don Seiffert: @donseiffert.bsky.social (@seiffertdon) 's Twitter Profile Photo

The CEO of one of the area's largest and fastest-growing biotechs, Alnylam Pharmaceuticals is stepping down in 2022 after a 19-year tenure. He will be replaced by Yvonne Greenstreet, who would become one of the few Black woman CEOs in biotech, via Rowan Walrath $ALNY bizj.us/1qckc9

Doug Banks (@edougbanks) 's Twitter Profile Photo

NEW THIS A.M.: George Church discusses the science behind GRO Biosciences, which could provide a workaround for problems in protein therapeutics. The startup just hauled in $25M to tackle those problems. bizjournals.com/boston/news/20… via Boston Business Journal Rowan Walrath

Dan 🌎🌊🐋🐠 (@dsteketee97) 's Twitter Profile Photo

With $50M, Flagship Pioneering Makes Another Big RNA Play: Alltrna by Rowan Walrath 😷 and Boston Business Journal #science #mrna #altrna #solutions #pharmaceuticals #biotech #medical #medicine #healthcare #venturecapital #rna #futureishere lnkd.in/evMCvuAZ

Rowan Walrath 😷 (@rowanwalrath) 's Twitter Profile Photo

As more venture capital than ever pours into the Massachusetts life sciences industry, some startups are capitalizing on the trend by raising larger rounds up front. These are the largest 10 Series A rounds of the year so far. bizjournals.com/boston/news/20…

Rowan Walrath 😷 (@rowanwalrath) 's Twitter Profile Photo

Acrivon Therapeutics has raised $100 million to move a drug licensed from Former Account of Eli Lilly and Company through in-human trials. The company made its public launch just about four months ago. bizjournals.com/boston/news/20…

Rowan Walrath 😷 (@rowanwalrath) 's Twitter Profile Photo

Office buildings in Boston cut their emissions by 21% year-over-year in 2020. The big question is whether they will slingshot back to pre-Covid levels — or worse — as more employees return to the office. Great reporting from @BosBizCatherine & @bygregryan bizjournals.com/boston/news/20…

Don Seiffert: @donseiffert.bsky.social (@seiffertdon) 's Twitter Profile Photo

EXCLUSIVE cover story by Rowan Walrath & @BosBizCatherine: Boston is seeing a boom in lab development. But lab buildings are some of the worst producers of greenhouse gasses, which could complicate the city's efforts to rein in building emissions. bizjournals.com/boston/news/20…

Greg Ryan (@bosbizgregryan) 's Twitter Profile Photo

Great story from @BosBizCatherine & Rowan Walrath about the climate change implications of all this lab space taking over Boston. Last year, labs in Boston had 3x carbon emissions per square foot as offices, per BBJ analysis: bizjournals.com/boston/news/20…

Rowan Walrath 😷 (@rowanwalrath) 's Twitter Profile Photo

Hello. Some non-Covid numbers for a change: @BosBizCatherine and I took a deep dive into the greenhouse gas emissions from Boston's lab buildings last year. Highlights in 🧵 bizjournals.com/boston/news/20…